Health related quality of life in men with prostate cancer.
暂无分享,去创建一个
[1] C. McPherson,et al. Quality of life and treatment outcomes , 1997, Cancer.
[2] R. Deyo,et al. Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life , 1989, Medical care.
[3] J. Richie,et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] G. Fellin,et al. Assessment of quality of life after radical radiotherapy for prostate cancer. , 1996, British journal of urology.
[5] A. Brickman,et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. , 1995, The Journal of urology.
[6] M. Barry,et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. , 1995, Urology.
[7] R A Stephenson,et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.
[8] S P McKenna,et al. Measuring health status: a new tool for clinicians and epidemiologists. , 1985, The Journal of the Royal College of General Practitioners.
[9] R H Brook,et al. Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.
[10] T M Gill,et al. A critical appraisal of the quality of quality-of-life measurements. , 1994, JAMA.
[11] J. Stanford,et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. , 1999, Journal of the National Cancer Institute.
[12] G. Kennealey,et al. Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. , 1995, Urology.
[13] W. Lee,et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[14] J. Richie,et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. , 1997, Journal of the National Cancer Institute.
[15] H M Sandler,et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.
[16] J. Ware,et al. Health-related quality of life among patients with metastatic prostate cancer. , 1997, Urology.
[17] S. Fosså,et al. Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG) , 1997, European journal of cancer.
[18] M. Litwin,et al. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. , 1998, American journal of clinical oncology.
[19] D. Patrick,et al. Assessing health-related quality of life for clinical decision-making , 1993 .
[20] R. Heinrich,et al. Development of a comprehensive quality of life measurement tool: CARES. , 1990, Oncology.
[21] P. Schellhammer,et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. , 1999, Urology.
[22] A. Potosky,et al. Assessment of patient preferences among men with prostate cancer. , 1998, The Journal of urology.
[23] A McMurray,et al. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Huggins,et al. STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND , 1941 .
[25] A. Porter,et al. Quality of life after permanent prostate implant. , 1997, Seminars in surgical oncology.
[26] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[27] P. Fransson,et al. Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma , 1999, Cancer.
[28] D. Lubeck,et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. , 1998, The Journal of urology.
[29] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] D S Tulsky,et al. An introduction to test theory. , 1990, Oncology.
[31] P. Ganz,et al. CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument , 1991, Cancer.
[32] H. Herr,et al. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. , 2000, The Journal of urology.
[33] D. Lubeck,et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. , 1999, Urology.
[34] S. Malkowicz,et al. Erectile function and quality of life after interstitial radiation therapy for prostate cancer , 2000, International Journal of Impotence Research.
[35] P. Johnstone,et al. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. , 2000, International journal of radiation oncology, biology, physics.
[36] D. Lubeck,et al. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. , 1999, Urology.
[37] M. Litwin,et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. , 2000, The Journal of urology.
[38] K. Pienta,et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. , 1997, Urology.
[39] Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic Trial , 1998 .
[40] S. Walker,et al. Quality of Life Assessment: Key Issues in the 1990s , 1993, Springer Netherlands.
[41] P. Fransson,et al. Self‐assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age‐matched control population , 1994, Cancer.
[42] D. Osoba,et al. Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[44] P. Ditonno,et al. Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] D. Smith,et al. Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer. , 1999, Oncology nursing forum.
[46] Y. Ohashi,et al. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. , 1999, Urology.
[47] R H Brook,et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. , 1998, Medical care.